BBVA
IOVA icon

Banco Bilbao Vizcaya Argentaria’s Iovance Biotherapeutics IOVA Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$69.7K Buy
+20,000
New +$64K ﹤0.01% 724

Other funds holding IOVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's IOVA Position: Q1 2026 in Review

Banco Bilbao Vizcaya Argentaria opened a new position in Iovance Biotherapeutics (IOVA) in Q1 2026: 20,000 shares worth $69.7K. The stake represents ﹤0.01% of the portfolio and ranks #724 among its holdings.

285 funds tracked by Wall St. Rank hold IOVA as of Q1 2026.

  • Banco Bilbao Vizcaya Argentaria held 20,000 shares of Iovance Biotherapeutics worth $69.7K as of Q1 2026.
  • Iovance Biotherapeutics was a new Banco Bilbao Vizcaya Argentaria position in Q1 2026.
  • Iovance Biotherapeutics made up ﹤0.01% of Banco Bilbao Vizcaya Argentaria's portfolio in Q1 2026, its #724 holding.
  • 285 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2026.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q1 2026, filed 14 May 2026.